Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Esreboxetine

A norepinephrine reuptake inhibitor studied as a possible treatment for neuropathic pain and fibromyalgia; its clinical development was stopped in 2009. This family brings together metabolites.

Did you know?It is one of the two mirror-image forms (enantiomers) of reboxetine, the (S,S) one: separated from its 'twin', it is even more selective for norepinephrine than the parent drug.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.